MedTrace Logo

RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent

NCT00927940 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2015-05-05

Study results available
· View outcomes & findings →

Summary

The objective of the study is to verify the safety and efficacy of the MDT-4107 Drug-Eluting Coronary Stent for the treatment of de novo lesions in native coronary arteries.

Conditions

Interventions

DEVICE

MDT-4107 Drug Eluting Stent

Implantation of a MDT-4107 Zotarolimus-Eluting Coronary Stent

Sponsors & Collaborators

  • Medtronic Japan Co., Ltd.

    collaborator INDUSTRY

  • Medtronic Vascular

    lead INDUSTRY

Principal Investigators

  • Shigeru Saito, MD · Shonan Kamakura General Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2010-12-31
Completion
2015-02-28

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00927940 on ClinicalTrials.gov